Ara
Toplam kayıt 1, listelenen: 1-1
Bevacizumab + Capecitabine As Maintenance Therapy After Initial Bevacizumab + Xelox Treatment In Previously Untreated Patients with Metastatic Colorectal Cancer: Phase Ill 'Stop And Go' Study Results - A Turkish Oncology Group Trial
(Karger, 2013)
Objective: It was the aim of this study to evaluate maintenance therapy with bevacizumab + capecitabine following induction with bevacizumab + capecitabine + oxaliplatin (XELOX) versus bevacizumab + XELOX until progression ...